TIL compared with OM: revenue, margins and what each company keeps, and the suppliers and customers both name

TILInstil Bio, Inc.

Mkt capRevenueRevenue

OMOutset Medical, Inc.

Mkt capRevenueRevenue

Compare

TILInstil Bio, Inc.

OMOutset Medical, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TIL1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+1.51%—

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±26.3%▼−7.66%×0.29

Aug 7 '26±24.1%▼−5.77%×0.24

= impliedTIL realized, solidOM realized, hatchedOne scale, both sides: full bar = 40%× = |realized| ÷ impliedSource: market data

Q2 FY26

±39.4%

▲+25.62%

×0.65

Q1 FY26±17.2%▼−21.05%×1.23

TILInstil Bio, Inc.

6.83▼−2.29%· post 6.83

Mkt cap$46.3MRevenue—Revenue—

OMOutset Medical, Inc.

4.20▲+2.44%· post 4.20

ClosedNov 6 '26

Mkt cap$79.8MRevenue$34MQ3 FY26Revenue$119MFY25

Compare

ClosedNov 6 '26

TILInstil Bio, Inc.

OMOutset Medical, Inc.

6.83▼−2.29%post 6.83

Price

4.20▲+2.44%post 4.20

$46.3M

Mkt cap

$79.8M

—

Revenue

$34MQ3 FY26

—

Revenue

$119MFY25

TIL6.83▼−2.29%vsOM4.20▲+2.44%ClosedNov 6 '26